William Tap
MD
Chief of Sarcoma Medical Oncology
👥Biography 个人简介
William Tap leads the sarcoma oncology program at MSK and has made landmark contributions to histology-specific sarcoma treatment. He led the pivotal ENLIVEN trial of pexidartinib for tenosynovial giant cell tumor and contributed to MDM2-CDK4 inhibitor studies in well-differentiated liposarcoma. His research established pazopanib as a standard of care in non-adipocytic soft tissue sarcoma through the PALETTE trial. He continues to develop rational targeted approaches based on sarcoma molecular drivers.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 William Tap 的研究动态
Follow William Tap's research updates
留下邮箱，当我们发布与 William Tap（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment